146 related articles for article (PubMed ID: 27228988)
21. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.
Maurice M; Verhoeyen E; Salmon P; Trono D; Russell SJ; Cosset FL
Blood; 2002 Apr; 99(7):2342-50. PubMed ID: 11895766
[TBL] [Abstract][Full Text] [Related]
22. Systematic determination of the packaging limit of lentiviral vectors.
Kumar M; Keller B; Makalou N; Sutton RE
Hum Gene Ther; 2001 Oct; 12(15):1893-905. PubMed ID: 11589831
[TBL] [Abstract][Full Text] [Related]
23. Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55 Gag.
Aoki T; Shimizu S; Urano E; Futahashi Y; Hamatake M; Tamamura H; Terashima K; Murakami T; Yamamoto N; Komano J
Gene Ther; 2010 Sep; 17(9):1124-33. PubMed ID: 20410927
[TBL] [Abstract][Full Text] [Related]
24. Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases.
Mock U; Riecken K; Berdien B; Qasim W; Chan E; Cathomen T; Fehse B
Sci Rep; 2014 Sep; 4():6409. PubMed ID: 25230987
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
26. Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells.
Goujon C; Jarrosson-Wuilleme L; Bernaud J; Rigal D; Darlix JL; Cimarelli A
J Virol; 2003 Sep; 77(17):9295-304. PubMed ID: 12915545
[TBL] [Abstract][Full Text] [Related]
27. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
Bartosch B; Cosset FL
Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
[TBL] [Abstract][Full Text] [Related]
28. Coordinate enhancement of transgene transcription and translation in a lentiviral vector.
Yilmaz A; Fernandez S; Lairmore MD; Boris-Lawrie K
Retrovirology; 2006 Feb; 3():13. PubMed ID: 16480517
[TBL] [Abstract][Full Text] [Related]
29. Production and purification of lentiviral vectors.
Tiscornia G; Singer O; Verma IM
Nat Protoc; 2006; 1(1):241-5. PubMed ID: 17406239
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel trans-lentiviral vector that affords predictable safety.
Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
[TBL] [Abstract][Full Text] [Related]
31. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
[TBL] [Abstract][Full Text] [Related]
32. Use of HIV as a gene transfer vector.
Pluta K; Kacprzak MM
Acta Biochim Pol; 2009; 56(4):531-95. PubMed ID: 19936329
[TBL] [Abstract][Full Text] [Related]
33. Postexit surface engineering of retroviral/lentiviral vectors.
Metzner C; Kochan F; Dangerfield JA
Biomed Res Int; 2013; 2013():253521. PubMed ID: 23691494
[TBL] [Abstract][Full Text] [Related]
34. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference.
Westerhout EM; ter Brake O; Berkhout B
Retrovirology; 2006 Sep; 3():57. PubMed ID: 16948865
[TBL] [Abstract][Full Text] [Related]
35. A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors.
Berger G; Durand S; Goujon C; Nguyen XN; Cordeil S; Darlix JL; Cimarelli A
Nat Protoc; 2011 Jun; 6(6):806-16. PubMed ID: 21637200
[TBL] [Abstract][Full Text] [Related]
36. Lentiviral vectors: basic to translational.
Sakuma T; Barry MA; Ikeda Y
Biochem J; 2012 May; 443(3):603-18. PubMed ID: 22507128
[TBL] [Abstract][Full Text] [Related]
37. HIV-derived vectors for therapy and vaccination against HIV.
Di Nunzio F; Félix T; Arhel NJ; Nisole S; Charneau P; Beignon AS
Vaccine; 2012 Mar; 30(15):2499-509. PubMed ID: 22342915
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
[TBL] [Abstract][Full Text] [Related]
39. Advances in lentiviral vectors: a patent review.
Picanco-Castro V; de Sousa Russo-Carbolante EM; Tadeu Covas D
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):82-90. PubMed ID: 22670608
[TBL] [Abstract][Full Text] [Related]
40. Generation of a new Gateway-compatible inducible lentiviral vector platform allowing easy derivation of co-transduced cells.
De Groote P; Grootjans S; Lippens S; Eichperger C; Leurs K; Kahr I; Tanghe G; Bruggeman I; De Schamphelaire W; Urwyler C; Vandenabeele P; Haustraete J; Declercq W
Biotechniques; 2016; 60(5):252-9. PubMed ID: 27177818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
